Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
RF
|
David R. Keenan
SEVP |
BUY
Exercise of conversion of derivative security
|
Direct | 29,016 Added 32.02% |
-
|
Apr 03
2020 |
|
RF
|
Hardie B. Kimbrough Jr
Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 9,673 Added 46.17% |
-
|
Apr 03
2020 |
|
RF
|
C. Matthew Lusco
SEVP & CRO |
BUY
Exercise of conversion of derivative security
|
Direct | 58,035 Added 20.78% |
-
|
Apr 03
2020 |
|
RF
|
John B Owen
SEVP & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 58,035 Added 28.56% |
-
|
Apr 03
2020 |
|
RF
|
Scott M. Peters
SEVP |
SELL
Payment of exercise price or tax liability
|
Direct | 12,870 Reduced 16.19% |
$103,861
$8.07 p/Share
|
Apr 03
2020 |
|
RF
|
Scott M. Peters
SEVP |
BUY
Exercise of conversion of derivative security
|
Direct | 29,016 Added 26.74% |
-
|
Apr 03
2020 |
|
RF
|
William D. Ritter
SEVP |
SELL
Payment of exercise price or tax liability
|
Direct | 12,870 Reduced 14.44% |
$103,861
$8.07 p/Share
|
Apr 03
2020 |
|
RF
|
William D. Ritter
SEVP |
BUY
Exercise of conversion of derivative security
|
Direct | 29,016 Added 24.56% |
-
|
Apr 03
2020 |
|
RF
|
Ronald G. Smith
SEVP |
SELL
Payment of exercise price or tax liability
|
Direct | 12,870 Reduced 4.44% |
$103,861
$8.07 p/Share
|
Apr 03
2020 |
|
RF
|
Ronald G. Smith
SEVP |
BUY
Exercise of conversion of derivative security
|
Direct | 29,016 Added 9.1% |
-
|
Apr 03
2020 |
|
RF
|
John M Turner Jr
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 58,035 Added 14.8% |
-
|
Apr 03
2020 |
|
AMT
|
Robert Joseph Meyer Jr
SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 22 Reduced 0.07% |
$4,902
$222.8 p/Share
|
Apr 03
2020 |
|
MDT
|
Denise M Oleary
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 929 Reduced 1.4% |
$80,145
$86.27 p/Share
|
Apr 03
2020 |
|
MDT
|
Denise M Oleary
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,813 Added 2.65% |
$80,008
$44.13 p/Share
|
Apr 03
2020 |
|
CVS
|
Larry J Merlo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 9,803 Reduced 1.84% |
$546,223
$55.72 p/Share
|
Apr 03
2020 |
|
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,017 Reduced 1.42% |
$56,667
$55.72 p/Share
|
Apr 03
2020 |
|
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,598 Reduced 3.32% |
$89,041
$55.72 p/Share
|
Apr 03
2020 |
|
CVS
|
Thomas M Moriarty
EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,944 Reduced 5.53% |
$219,760
$55.72 p/Share
|
Apr 03
2020 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,179 Reduced 2.03% |
$121,414
$55.72 p/Share
|
Apr 03
2020 |
|
SPWR
|
Total S.A.
Director |
BUY
Open market or private purchase
|
Indirect | 647,511 Added 0.74% |
$3,082,153
$4.76 p/Share
|
Apr 03
2020 |
|
RTX
|
Robert Kelly Ortberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 81 Added 0.1% |
-
|
Apr 03
2020 |
|
INTC
|
George S Davis
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,689 Reduced 16.32% |
$414,668
$53.93 p/Share
|
Apr 03
2020 |
|
INTC
|
George S Davis
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,507 Added 24.76% |
-
|
Apr 03
2020 |
|
VZ
|
Hans Erik Vestberg
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,140 Reduced 11.79% |
$390,558
$54.7 p/Share
|
Apr 03
2020 |
|
VZ
|
Hans Erik Vestberg
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 13,957 Added 18.73% |
-
|
Apr 03
2020 |
|
COF
|
Timothy P Golden
Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,755 Reduced 9.59% |
$74,184
$42.27 p/Share
|
Apr 03
2020 |
|
CRNX
|
Vivo Capital Viii, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 300,000 Reduced 9.68% |
$4,140,000
$13.8 p/Share
|
Apr 03
2020 |
|
HTH
|
W Robert Nichols Iii |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$291,800
$14.59 p/Share
|
Apr 03
2020 |
|
STON
|
Mangrove Partners Master Fund, Ltd. |
SELL
Open market or private sale
|
Direct | 171,458 Reduced 1.8% |
$128,594
$0.75 p/Share
|
Apr 03
2020 |
|
PCYO
|
Plaisance Spv I, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 20,000 Added 0.73% |
$168,800
$8.44 p/Share
|
Apr 03
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3 Added 0.0% |
$1,374
$457.87 p/Share
|
Apr 03
2020 |
|
FITB
|
Jude Schramm
EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 994 Reduced 3.75% |
$14,194
$14.28 p/Share
|
Apr 03
2020 |
|
CZNC
|
Timothy E Schoener |
BUY
Open market or private purchase
|
Direct | 284 Added 16.67% |
$4,970
$17.5 p/Share
|
Apr 03
2020 |
|
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 426 Added 3.13% |
$7,455
$17.5 p/Share
|
Apr 03
2020 |
|
CZNC
|
Bobbi J Kilmer |
BUY
Open market or private purchase
|
Direct | 355 Added 6.34% |
$6,212
$17.5 p/Share
|
Apr 03
2020 |
|
NKE
|
John W Rogers Jr
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 7.22% |
$78,610
$78.61 p/Share
|
Apr 03
2020 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 26,723 Reduced 0.02% |
$3,831,009
$143.36 p/Share
|
Apr 03
2020 |
|
CRM
|
John Victor Roos
Director |
SELL
Open market or private sale
|
Direct | 119 Reduced 1.34% |
$16,000
$134.45 p/Share
|
Apr 03
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.03% |
$1,341,400
$134.14 p/Share
|
Apr 03
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Apr 03
2020 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 1.64% |
$362,419
$32.81 p/Share
|
Apr 03
2020 |
|
MRNA
|
Juan Andres
Officer |
SELL
Open market or private sale
|
Direct | 13,697 Reduced 100.0% |
$480,628
$35.09 p/Share
|
Apr 03
2020 |
|
MRNA
|
Juan Andres
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 13,697 Added 50.0% |
$167,240
$12.21 p/Share
|
Apr 03
2020 |
|
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 22.34% |
$328,100
$32.81 p/Share
|
Apr 03
2020 |
|
CCK
|
Gerard H Gifford
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,646 Reduced 1.04% |
$86,678
$52.66 p/Share
|
Apr 03
2020 |
|
CCK
|
Gerard H Gifford
EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 807 Added 0.51% |
-
|
Apr 03
2020 |
|
CCK
|
Didier Sourisseau
President, European Division |
SELL
Payment of exercise price or tax liability
|
Direct | 1,042 Reduced 1.25% |
$54,872
$52.66 p/Share
|
Apr 03
2020 |
|
CCK
|
Didier Sourisseau
President, European Division |
BUY
Grant, award, or other acquisition
|
Direct | 2,392 Added 2.78% |
-
|
Apr 03
2020 |
|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 4,100 Added 0.29% |
$36,654
$8.94 p/Share
|
Apr 03
2020 |
|
FPH
|
Luxor Capital Group, LP |
BUY
Open market or private purchase
|
Indirect | 73,300 Added 0.45% |
$341,578
$4.66 p/Share
|
Apr 03
2020 |